Bellerophon Therapeutics, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 35224520, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2017-06-30) |
| Status | current |
| Entity | Bellerophon Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/30d4cabe-a9f2-4f7b-9586-e61732137448
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001600132-17-000082 · Open the official SEC filing →Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001600132/common-shares-issued/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/30d4cabe-a9f2-4f7b-9586-e61732137448
History
- no predecessors — first report